GENOMIC DATA LEADERS

About Ovation

We’re on a mission to advance human health by enabling the use of molecular and human genomic data at scale in research.

Our Mission

Ovation is a genomic data company committed to unlocking the potential of human genomic data at scale and accelerating precision medicine development.

By providing access to high-quality genomic data linked to rich, longitudinal phenotypic data at scale, Ovation allows life sciences researchers to advance drug discovery and development more efficiently. Ovation’s cloud-based LIMS and Ovation Research Network, enable a diverse network of clinical laboratories to quickly adopt innovative molecular tests while biobanking and transforming remnant samples to be used for research.

Our Leadership Team

Our leadership team is comprised of industry veterans who have a wealth of experience across life sciences, healthcare data, scientific research, technology, and clinical diagnostics industries.

Curt Medeiros

Curt Medeiros

Chief Executive Officer

Winston Brasor

Winston Brasor

Co-Founder and GM LIMS

Barry Wark, PhD

Barry Wark, PhD

Co-Founder & Chief Strategy Officer

Ed Stepanski, PhD

Ed Stepanski, PhD

General Manager, Data

Pauline Gee, PhD

Pauline Gee, PhD

Vice President, Clinical Affairs

Zane Schafer

Zane Schafer

Chief Technology Officer

Chris Hargarten

Chris Hargarten

Sr. Director Product Management, Data

Martin Miller

Martin Miller

Chief Revenue Officer

Emma Bagley

Emma Bagley

Head of HR

Su Shen

Su Shen

Sr. Director Product Management, LIMS

Our Investors

Ovation and DNAnexus Present at the 2nd Precision Medicine in IBD Summit

Learn about the transformative power of leveraging high-value multiomics data alongside an advanced..

Linking Genomic and Phenotypic Data to Better Understand the Patient Journey

In partnership with Datavant, we explore how researchers can overcome the challenges posed by..

We looking forward to speaking with you!